These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 2557776

  • 21. Characterization of the inhibition of U46619-mediated human platelet activation by the trimetoquinol isomers. Evidence for endoperoxide/thromboxane A2 receptor blockade.
    Ahn CH, Romstedt KJ, Wallace LJ, Miller DD, Feller DR.
    Biochem Pharmacol; 1988 Aug 01; 37(15):3023-33. PubMed ID: 3134894
    [Abstract] [Full Text] [Related]

  • 22. BM 13.177, a selective blocker of platelet and vessel wall thromboxane receptors, is active in man.
    Gresele P, Deckmyn H, Arnout J, Lemmens J, Janssens W, Vermylen J.
    Lancet; 1984 May 05; 1(8384):991-4. PubMed ID: 6143969
    [Abstract] [Full Text] [Related]

  • 23. Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism.
    Macconi D, Morzenti G, Livio M, Morelli C, Cassina G, Remuzzi G.
    Lab Invest; 1985 Feb 05; 52(2):159-68. PubMed ID: 3155816
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Role of thromboxane A2.
    Ambler J, Birch J, Maguire ED, Wallis RB.
    Adv Exp Med Biol; 1985 Feb 05; 192():293-308. PubMed ID: 2939695
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Propofol inhibits human platelet aggregation induced by proinflammatory lipid mediators.
    Fourcade O, Simon MF, Litt L, Samii K, Chap H.
    Anesth Analg; 2004 Aug 05; 99(2):393-8, table of contents. PubMed ID: 15271713
    [Abstract] [Full Text] [Related]

  • 28. "In vitro" and "ex vivo" effects of picotamide, a combined thromboxane A2-synthase inhibitor and -receptor antagonist, on human platelets.
    Berrettini M, De Cunto M, Parise P, Grasselli S, Nenci GG.
    Eur J Clin Pharmacol; 1990 Aug 05; 39(5):495-500. PubMed ID: 1963845
    [Abstract] [Full Text] [Related]

  • 29. Effect of phorbol 12-myristate 13-acetate (PMA) on agonist-induced arachidonate release and 5-hydroxytryptamine secretion in human platelets. Dependence of effects on agonist type and time of incubation with PMA.
    Krishnamurthi S, Joseph S, Kakkar VV.
    Biochim Biophys Acta; 1987 Mar 11; 927(3):429-36. PubMed ID: 3101746
    [Abstract] [Full Text] [Related]

  • 30. Influence of SK&F 95587 and BN 50730 on bronchoconstrictor responses in the cat.
    Dyson MC, Bellan JA, Minkes RK, Beckerman RC, Wegmann MJ, Braquet P, McNamara DB, Kadowitz PJ.
    J Pharmacol Exp Ther; 1990 Dec 11; 255(3):1320-7. PubMed ID: 2175802
    [Abstract] [Full Text] [Related]

  • 31. Two different sites of action for platelet activating factor and 1-O-alkyl-2-O-methyl-sn-glycero-3-phosphocholine on platelets and leukemic cells.
    Salari H, Dryden P, Howard S, Bittman R.
    Biochem Cell Biol; 1992 Feb 11; 70(2):129-35. PubMed ID: 1324692
    [Abstract] [Full Text] [Related]

  • 32. Antagonism of U46619-induced aggregation of human and canine platelets by four TXA2 receptor antagonists.
    Bush LR, Smith SG.
    Thromb Res; 1986 Nov 01; 44(3):377-89. PubMed ID: 2948294
    [Abstract] [Full Text] [Related]

  • 33. Labeling of human platelet plasma membrane thromboxane A2/prostaglandin H2 receptors using SQB, a novel biotinylated receptor probe.
    Komiotis D, Wencel-Drake JD, Dieter JP, Lim CT, Le Breton GC.
    Biochem Pharmacol; 1996 Sep 13; 52(5):763-70. PubMed ID: 8765474
    [Abstract] [Full Text] [Related]

  • 34. The potent inhibition of vapiprost, a novel thromboxane A2 receptor antagonist, on the secondary aggregation and ATP release of human platelets.
    Horie S, Yamada M, Satoh M, Noritake S, Hiraishi S, Kizaki K, Kurusu O, Nakahara T, Ishii H, Kazama M.
    Biol Pharm Bull; 1997 Jun 13; 20(6):625-31. PubMed ID: 9212979
    [Abstract] [Full Text] [Related]

  • 35. Eicosapentaenoic acid and docosahexaenoic acid are antagonists at the thromboxane A2/prostaglandin H2 receptor in human platelets.
    Swann PG, Venton DL, Le Breton GC.
    FEBS Lett; 1989 Jan 30; 243(2):244-6. PubMed ID: 2537230
    [Abstract] [Full Text] [Related]

  • 36. Effect of thromboxane A2 synthetase inhibition, singly and combined with thromboxane A2/prostaglandin endoperoxide receptor antagonism, on inositol phospholipid turnover and on 5-HT release by washed human platelets.
    de Chaffoy de Courcelles D, De Clerck F.
    Eur J Pharmacol; 1990 Mar 13; 188(2-3):161-9. PubMed ID: 2318257
    [Abstract] [Full Text] [Related]

  • 37. Irreversible inhibition of the TXA2/PGH2 receptor of human platelets by a photoaffinity ligand.
    Zehender H, Witte EC, Wolff HP, Patscheke H.
    Biochem Pharmacol; 1988 Feb 01; 37(3):491-5. PubMed ID: 2962585
    [Abstract] [Full Text] [Related]

  • 38. The inhibition of platelet-activating factor-induced platelet activation by oleic acid is associated with a decrease in polyphosphoinositide metabolism.
    Nunez D, Randon J, Gandhi C, Siafaka-Kapadai A, Olson MS, Hanahan DJ.
    J Biol Chem; 1990 Oct 25; 265(30):18330-8. PubMed ID: 2170407
    [Abstract] [Full Text] [Related]

  • 39. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
    Yu SM, Wu TS, Teng CM.
    Br J Pharmacol; 1994 Mar 25; 111(3):906-12. PubMed ID: 8019768
    [Abstract] [Full Text] [Related]

  • 40. Desensitization of platelet thromboxane A2/prostaglandin H2 receptors by the mimetic U46619.
    Liel N, Mais DE, Halushka PV.
    J Pharmacol Exp Ther; 1988 Dec 25; 247(3):1133-8. PubMed ID: 2974487
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.